Press Releases
Press Release
Cardiol Therapeutics Receives Health Canada Approval for Phase II Clinical Trial of CardiolRx™ for Acute Myocarditis
October 25, 2021
Press Release
Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRx™, into Brazil, Mexico, and Canada
October 18, 2021
Press Release
Cardiol Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference
September 16, 2021
Press Release
Cardiol Therapeutics Announces Acceleration of Expiry Date of Warrants issued on June 4, 2020
September 10, 2021
Press Release
Cardiol Therapeutics Appoints Michael J. Willner to its Board of Directors
September 07, 2021
Press Release
Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for Phase II Clinical Trial of CardiolRx™ for Acute Myocarditis
August 24, 2021
Press Release
Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol “CRDL”
August 09, 2021
Press Release
Cardiol Therapeutics’ Board of Directors Appoints Dr. Guillermo Torre-Amione as Chairman
July 07, 2021
Press Release
Cardiol Therapeutics Reports Results of 2021 Annual General and Special Meeting
June 30, 2021